Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Cyclosporine in the Treatment of Angioimmunoblastic T-Cell Lymphoma

NCT00070291 is registered in ClinicalTrials.gov with Eastern Cooperative Oncology Group as lead sponsor.

NCT NCT00070291
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00070291 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Cyclosporine in the Treatment of Angioimmunoblastic T-Cell Lymphoma
Lead sponsor
Eastern Cooperative Oncology Group
Phase
Phase 2
Overall status
Terminated
Start date
January 24, 2006
Completion date
May 31, 2011
Enrollment
4 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma